Stress and relapse to drug seeking: Studies in laboratory animals shed light on mechanisms and sources of long-term vulnerability

American Journal on Addictions

Volumn 12, Issue 1, 2003, Pages 1-17

  Stewart, Jane ^a  

^a and Applied Physiology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,6 DIETHYLANILINO) 2 IMIDAZOLINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CLONIDINE; COCAINE; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR[12-41][DEXTRO PHENYLALANINE]; DIAMORPHINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FLUPENTIXOL DECANOATE; GUANABENZ; ICI 181555; LOFEXIDINE; METHADONE; METYRAPONE; NALOXONE; NALTREXONE; NICOTINE; OPIATE; RACLOPRIDE; TETRODOTOXIN; UNCLASSIFIED DRUG;

ALCOHOLISM; BEHAVIORAL SCIENCE; BRAIN REGION; CORTICOSTERONE BLOOD LEVEL; DISSOCIATION; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; EXPERIENCE; EXPERIMENTAL ANIMAL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROCHEMISTRY; NONHUMAN; NORADRENERGIC SYSTEM; PREFRONTAL CORTEX; RELAPSE; REVIEW; SHOCK; STRESS; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

EID: 0037219299     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2003.tb00535.x     Document Type: Review

References (98)

1. Meyer R, Mirin SM. The Heroin Stimulus Implications for a Theory of Addiction. New York: Plenum; 1979.
2. Jaffe JH, Cascell NG, Kumor KM, Sherer MA. Cocaine-induced cocaine craving. Psychopharmacology 1989;97:59-64.
3. de Wit H. Priming effects with drugs and other reinforcers. Exp Clin Psychopharmacol. 1996;4:5-10.
4. Carroll ME, Comer SD. Animal models of relapse. Exp Clin Psychopharmacol. 1996;4:11-18.
5. Stewart J. Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci. 2000;25:125-136.
6. Childress AR, Ehrman R, Rohsenow DJ, Robbins SJ, O'Brien CP. Classically conditioned factors in drug dependence. In: Lowinson JW, Ruiz P, Millman RB, Langrod G, eds. Substance Abuse: A Comprehensive Textbook. Baltimore: Williams and Wilkins; 1992:56-69.
7. Carter BL, Tiffany ST. Meta-analysis of cue reactivity in addiction research. Addiction. 1999;94.
8. See RE. Neural substrates of conditioned-cued relapse to drug-seeking behavior. Pharmacol Biochem Behav. Mar 2002;71:517-529.
9. Kosten TR, Rounsaville BJ, Kleber HD. A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Arch Gen Psychiatry. 1986;43:733-739.
10. Kreek MJ, Koob GF. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 1998;51:23-47.
11. Sinha R, Catapano D, O'Malley S. Stress-induced craving and stress response in cocaine-dependent individuals. Psychopharmacology. 1999;142:343-351.
12. Shaham Y, Erb S, Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Rev. 2000;33:13-33.
13. Erb S, Shaham Y, Stewart J. Stress-induced relapse to drug seeking in the rat: role of the bed nucleus of the stria terminalis and amygdala. Stress. 2001;4:289-303.
14. Stewart J. Pathways to relapse: factors controlling the reinitiation of drug seeking after abstinence. In: Bevins RA, Bardo MT, eds. The Nebraska Symposium on Motivation: Motivational Factors in the Etiology of Drug Abuse. Lincoln: University of Nebraska Press; in press.
15. Shalev U, Grimm JW, Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev. 2002;54:1-42.
16. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science. 1997;278: 52-58.
17. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001;24:97-129.
18. Leith NJ, Barrett RJ. Amphetamine and the reward system: evidence for tolerance and post-drug depression. Psychopharmacologia. 1976;46:19-25.
19. Frank RA, Martz S, Pommering T. The effect of chronic cocaine on self-stimulation trainduration thresholds. Pharmacol Biochem Behav. Apr 1988;29:755-758.
20. Kokkinidis L, McCarter BD. Postcocaine depression and sensitization of brain-stimulation reward: analysis of reinforcement and performance effects. Pharmacol Biochem Behav. 1990;36:463-471.
21. Markou A, Koob GF. Postcocaine anhedonia: an animal model of cocaine withdrawal. Neuropsychopharmacology. 1991;4:17-26.
22. Wise RA, Munn E. Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds. Psychopharmacology. 1995;117:130-136.
23. Lin D, Koob GF, Markou A. Time-dependent alterations in ICSS thresholds associated with repeated amphetamine administrations. Pharmacol Biochem Behav. 2000;65:407-417.
24. Ahmed SH, Kenny PJ, Koob GF, Markou A. Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat Neurosci. 2002;5:625-626.
25. Ahmed SH, Koob GF. Transition from moderate to excessive drug intake: change in hedonic set point. Science. 1998;282:298-300.
26. Ahmed SH, Koob GF. Long-lasting increase in the set point for cocaine self-administration after escalation in rats. Psychopharmacology. 1999;146:303-312.
27. Frank RA, Manderscheid PZ, Panicker S, Williams HP, Kokoris D. Cocaine euphoria, dysphoria, and tolerance assessed using drug-induced changes in brain-stimulation reward. Pharmacol Biochem Behav. 1992;42: 771-779.
28. Vezina P, Lorrain DS, Arnold GM, Austin JD, Suto N. Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J Neurosci. 2002;22:4654-4662.
29. de Wit H, Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology. 1981;75:134-143.
30. de Wit H, Stewart J. Drug reinstatement of heroin-reinforced responding in the rat. Psychopharmacology. 1983;79:29-31.
31. Stewart J, de Wit H. Reinstatement of drug-taking behavior as a method of assessing incentive motivational properties of drugs. In: Bozarth MA, ed. Methods of Assessing the Reinforcing Properties of Abused Drugs. New York: Springer-Verlag; 1987:211-227.
32. Shaham Y, Rodaros D, Stewart J. Reinstatement of heroin-reinforced behavior following long-term extinction: implications for the treatment of relapse to drug-taking. Behav Pharmacol. 1994;5:360-364.
33. Shaham Y, Stewart J. Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology. 1995;119:334-341.
34. Shaham Y, Rajabi H, Stewart J. Relapse to heroin-seeking under opioid maintenance: the effects of opioid withdrawal, heroin priming, and stress. J Neurosci. 1996;16:1957-1963.
35. Shaham Y, Stewart J. Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats. Psychopharmacology. 1996;125:385-391.
36. Buczek Y, Le AD, Stewart J, Shaham Y. Stress reinstates nicotine seeking but not sucrose solution seeking in rats. Psychopharmacology. 1999;144:183-188.
37. Lê AD, Quan B, Juzytsch W, Fletcher PJ, Joharchi N, Shaham Y. Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology. 1998;135:169-174.
38. Ahmed SH, Koob GF. Cocaine- but not food-seeking behavior is reinstated by stress after extinction. Psychopharmacology. 1997;132:289-295.
39. Pechnick RN. Effects of opioids on the hypothalamo-pituitary-adrenal axis. Ann. Rev. Pharmacol Toxicol. 1993;32:353-383.
40. Torres G, Rivier C. Differential effects of intermittent or continuous exposure to cocaine on the hypothalamic-pituitary-adrenal axis and c-fos expression. Brain Res. 1992;571:204-211.
41. Piazza P-V, LeMoal M. Pathophysiological basis of vulnerability to drug abuse: interaction between stress, glucocorticoids and dopaminergic neurons. Ann. Rev. Pharmacol Toxicol. 1996;36:359-378.
42. Barr AM, Hofmann BA, Weinberg J, Phillips AG. Exposure to repeated, intermittent d-amphetamine induces sensitization of HPA axis to a subsequent stressor. Neuropsychopharmacology. 2002;26:286-294.
43. Schmidt ED, Tilders FJ, Janszen AW, Binnekade R, De Vries TJ, Schoffelmeer AN. Intermittent cocaine exposure causes delayed and long-lasting sensitization of cocaine-induced ACTH secretion in rats. Eur J Pharmacol. 1995;285:317-321.
44. Piazza P-V, Maccari S, Deminière J-M, LeMoal M, Mormède P. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci U S A. 1991;88:2088-2092.
45. Fahlke C, Hard E, Hansen S. Facilitation of ethanol consumption by intracerebroventricular infusions of corticosterone. Psychopharmacology. 1996;127:133-139.
46. Piazza P-V, Marinelli M, Jodogne C, et al. Inhibition of corticosterone synthesis by metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res. 1994;658:259-264.
47. Goeders NE, Guerin GF. Role of corticosterone in intravenous cocaine self-administration in rats. Neuroendocrinology. 1996;64:337-348.
48. Fahlke C, Eriksson CJ. Effect of adrenalectomy and exposure to corticosterone on alcohol intake in alcohol-preferring and alcohol-avoiding rat lines. Alcohol Alcohol. 2000;35:139-144.
49. Shaham Y, Funk D, Erb S, Brown TJ, Walker C-D, Stewart J. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci. 1997;17:2605-2614.
50. Erb S, Shaham Y, Stewart J. The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci. 1998;18:5529-5536.
51. Shaham Y, Erb S, Leung S, Buczek Y, Stewart J. CP- 154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor type 1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and herointrained rats. Psychopharmacology. 1998;137: 184-190.
52. Lê AD, Harding S, Juzytsch W, Watchus J, Shalev U, Shaham Y. The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology. 2000;150:317-324.
53. 1 receptor mRNA expression. J Neurosci. 1995;15:6340-6350.
54. Potter E, Sutton S, Donaldson C, et al. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA. 1994;91:8777-8781.
55. Davis M, Walker DL, Lee Y. Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex. Philos Trans R Soc Lond B Biol Sci. 1997;352:1675-1687.
56. Schulkin J, Gold PW, McEwen BS. Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology. 1998;23:219-243.
57. Erb S, Stewart J. A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci. 1999;19:RC35, 31-36.
58. Veinante P, Stoeckel M-E, Freund-Mercier M-J. GABA- and peptide-immunoreactivity co-localize in the rat central extended amygdala. Neuroreport. 1997;8:2985-2989.
59. Phelix CF, Paull WK. Demonstration of distinct corticotropin releasing factor-containing neuron populations in the bed nucleus of the stria terminalis. A light and electron microscopic immunocytochemical study in the rat. Histochemistry. 1990;94:345-364.
60. Sakanaka M, Shibasaki T, Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res. 1986;382: 213-238.
61. Chappell PB, Smith MA, Kilts CD, et al. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci. 1986;6:2908-2914.
62. Erb S, Salmaso N, Rodaros D, Stewart J. A role for the CRF-containing pathway from central nucleus of the amygdala to the bed nucleus of the stria terminalis in stress-induced relapse to cocaine seeking in rats. Psychopharmacology. 2001;158:360-365.
63. Moore RY, Bloom FE. Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Ann Rev Neurosci. 1979;2:113-168.
64. Aston-Jones G, Shipley MT, Grzanna R. The locus coeruleus, A5 and A7 noradrenergic cell groups. In: Paxinos G, ed. The Rat Nervous System. San Diego: Academic; 1995:183-213.
65. Tanaka M, Tsuda A, Yokoo H, Yoshida M, Ida Y, Mishimura H. Involvement of the brain noradrenaline system in emotional changes caused by stress in rats. Ann N Y Acad Sci. 1990;597:159-174.
66. Stanford SC. Central noradrenergic neurones and stress. Pharmacol Ther. 1995;68:297-342.
67. Berridge CW, Stratford TR, Foote SL, Kelley AE. Distribution of dopamine-beta-hydroxylase (DBH)- like immunoreactive fibers within the nucleus accumbens shell. Synapse. 1997;27:230-241.
68. Delfs JM, Zhu Y, Druhan JP, Aston-Jones GS. Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat. Brain Res. 1998;806:127-140.
69. Aston-Jones G, Delfs JM, Druhan J, Zhu Y. The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann N Y Acad Sci. 1999; 877:486-498.
70. Fritschy JM, Grzanna R. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system? Prog Brain Res. 1991;88:257-268.
71. Cecchi M, Khoshbouei H, Javors M, Morilak DA. Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuroscience. 2002;112:13-21.
72. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature. 2000;403:430-434.
73. Dunn AJ, Berridge CM. Physiological and behavioral responses to corticotropin-releasing-factor: is CRF a mediator of anxiety or stress responses? Brain Res Rev. 1990;15:71-100.
74. Valentino RJ, Foote SL, Page ME. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann N Y Acad Sci. 1993;697:173-188.
75. Phelix CF, Liposits Z, Paull WK. Catecholamine-CRF synaptic interaction in a septal bed nucleus: afferents of neurons in the bed nucleus of the stria terminalis. Brain Res Bull. 1994;33:109-119.
76. Cooper JR, Bloom FE, Roth RH. The biochemical basis of neuropharmacology. 5th ed. New York: Oxford University Press; 1986.
77. Mongeau R, Blier P, de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Rev. 1997;23:145-195.
78. Svensson TH, Bunney BS, Aghajanian GK. Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res. 1975;92:291-306.
79. Erb S, Hitchcott PK, Rajabi H, Mueller D, Shaham Y, Stewart J. Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology. 2000;23:138-150.
80. Scriabine A, Sweet CS, Ludde CT, Stavorski JM, Wenger HC, Bohidar NR. Some cardiovascular effects of ST-91 and clonidine. Eur J Pharmacol. 1975;43:333-341.
81. Shaham Y, Highfield D, Delfs J, Leung S, Stewart J. Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of the locus coeruleus noradrenergic neurons. Eur J Neurosci. 2000;12:292-302.
82. Hansen S, Stanfield EJ, Everitt BJ. The role of ventral bundle noradrenergic neurones in sensory components of sexual behaviour and coitus-induced pseudopregnancy. Nature. 1980;286:152-154.
83. McFarland K, Kalivas PW. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci. 2001;21: 8655-8663.
84. Shaham Y, Shalev U, Lu L, de Wit H, Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology [serial online]. October 26, 2002.
85. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP. Limbic activation during cue-induced cocaine craving. Am J Psychiatry. 1999;156:11-18.
86. Volkow ND, Fowler JS, Wolf AP, et al. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry. 1991;148:621-626.
87. Volkow ND, Fowler JS. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex. 2000;10:318-325.
88. Capriles N, Rodaros D, Stewart J. A role for the prefrontal cortex in stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology [serial online]. November 20, 2002.
89. Stewart J. Neurobiology of conditioning to drugs of abuse. In: Kalivas PW, Samson HH, eds. The Neurobiology of Drug and Alcohol Addiction. Annals of the New York Academy of Sciences. Vol 654. New York: New York Academy of Sciences; 1992:335-346.
90. Stewart J, de Wit H, Eikelboom R. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev. 1984;91:251-268.
91. Mueller D, Stewart J. Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction. Behav Brain Res. 2000;115:39-47.
92. Mueller D, Perdikaris D, Stewart J. Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference. Behav Brain Res. 2002;136:389-397.
93. Parker LA, McDonald RV. Reinstatement of both a conditioned place preference and a conditioned place aversion with drug primes. Pharmacol Biochem Behav. 2000;66:559-561.
94. Liu, X, Weiss F. Additive effect of stress and drug cues on reinstatement of ethanol seeking: Exacerbation by history of dependence and role of concurrent activation of corticotropin releasing factor and opiod mechanisms. J Neurosci. 2002;22:7856-7861.
95. Ahmed SH, Walker JR, Koob GF. Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology. 2000;22:413-421.
96. Robinson TE, Berridge KC. Incentive-sensitization and addiction. Addiction. 2001;96:103-114.
97. Grimm JW, Hope B, Wise RA, Shaham Y. Incubation of cocaine craving after withdrawal. Nature. 2001;412:141-142.
98. Shalev U, Hope B, Clements A, Morales M, Shaham Y. Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology. 2001;156:98-107.